- ►seen.es [PDF] U Smith, EAM Gale - Diabetologia, 2009 - Springer Abbreviations AMPK AMP-activated protein kinase FDA Food and Drug Administration HMEC
Human mammary epithelial cell MAPK Mitogen-activated protein kinase mTOR Mammalian target
of rapamycin NPH Neutral protamine Hagedorn THIN The Health Information Network Cited by 28 - Related articles - All 8 versions
DR Owens, GB Bolli - Diabetes Technology & Therapeutics, 2008 - liebertonline.com The new rDNA and DNA-derived “basal” insulin analogs, glargine and detemir, represent significant
ad- vancement in the treatment of diabetes compared with conventional NPH insulin. This review
describes blood glucose homeostasis by insulin in people without diabetes and outlines ... Cited by 7 - Related articles - All 3 versions
- ►nih.gov HM Colhoun - Diabetologia, 2009 - Springer Abstract Aims/hypothesis The aim of the present study was to examine whether patients with
diabetes in Scotland using insulin glargine have a greater cancer risk than patients using other
types of insulin. Methods We used a nationwide diabetes clinical database that covers the ... Cited by 5 - Related articles - All 5 versions
R Cordera, B Salani, L Briatore - Diabetes/Metabolism Reviews - interscience.wiley.com IGF-I and insulin, acting through both IGF-I and insulin receptors, have been studied widely to
evaluate their oncogenic and teratogenic properties. These two properties need to be studied
for each new insulin analogue, in addition to measurements of their metabolic and ... Related articles - All 2 versions
J Sandow - Archives Of Physiology And Biochemistry, 2009 - informahealthcare.com The definition of mitogenic activity of insulin is controversial. Under physiological conditions,
mitogenic refers to cell proliferation and tissue repair. In pathological conditions, it may refer
to stimulation of tumour cells in pre-existing (undiagnosed) tumours. The in vitro ... Cited by 1 - Related articles - All 7 versions
C Bonnesen, GM Nelander, BF Hansen, P Jensen, JS … - Cell Biology and … - Springer Abstract Evaluating mitogenic signaling specifically through the human insulin receptor (IR) is
relevant for the preclinical safety assessment of developmental insulin analogs. It is known that
overexpression of IR sensitizes cells to the mitogenic effects of insulin, but it is essentially ...
- ►easd.org [PDF] M Stumvoll, PP Nawroth - Diabetologia, 2009 - Springer It has happened again. Once more, the patient is left alone; once again, physicians are caught
between the conflicting forces of suspicion and company interest, emotions and experience,
traditions and personal relationships with industry representatives, colleagues and ... Related articles - All 3 versions
DMR Rev - Diabetes Metab Res Rev, 2009 - iddt.org Diabetes Metab Res Rev 2009; 25: 50–51. Published online 2009 in Wiley InterScience
(www.interscience.wiley.com) DOI: 10.1002/dmrr.934 ... Renzo Cordera,* Barbara Salani and
Lucia Briatore ... Department of Endocrinology and Medicine (DiSEM), University of ... Related articles - View as HTML - All 3 versions
L Insulinanaloga - iqwig.info Page 1. IQWiG-Berichte – Jahr: 2009 Nr. 42 Langwirksame Insulinanaloga zur Behandlung des
Diabetes mellitus Typ 2 Abschlussbericht Auftrag A05-03 Version 1.1 Stand: 26.02.2009 Page
2. Abschlussbericht A05-03 Langwirksame Insulinanaloga bei Diabetes mellitus Typ 2 ... Related articles - All 24 versions